Moore Matthew Richard — SEC Form 4 filings
SEC reporting owner CIK 1840191. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-17 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 8,149 shares, $79,470 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 4,681 shares @ $8.74 ($40,902) in Arcutis Biotherapeutics, Inc., filed 2024-05-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | SVP and Chief Business Officer | 4 | — | 2 legs · 8,149 sh · $79,470 | 13 |
| Ventyx Biosciences, Inc. (VTYX) | Chief Operating Officer | 3 | — | — | 4 |
Form 4 filings — Moore Matthew Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Ventyx Biosciences, Inc. (VTYX) | Disposition to issuer (D): 145,000 (derivative) · Disposition to issuer (D): 320,000 (derivative) | EDGAR |
| 2025-01-03 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 145,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 320,000 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 4,166 @ $0 · Sale (S): 4,681 @ $8.74 | EDGAR |
| 2024-03-06 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale (S): 3,468 @ $11.12 | EDGAR |
| 2024-02-15 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 26,666 · Grant/award (A): 26,666 · Grant/award (A): 17,650 · Grant/award (A): 19,750 · Grant/award (A): 4,166 · Disposition to issuer (D): 80,000 (derivative) · +4 more | EDGAR |
| 2024-01-17 | 4 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/award (A): 28,000 @ $0 · Grant/award (A): 126,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1840191 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →